• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹麦乳腺癌筛查内外 17 年概述。

Seventeen-years overview of breast cancer inside and outside screening in Denmark.

机构信息

Department of Public Health, University of Copenhagen, Denmark.

出版信息

Acta Oncol. 2013 Jan;52(1):48-56. doi: 10.3109/0284186X.2012.698750. Epub 2012 Sep 3.

DOI:10.3109/0284186X.2012.698750
PMID:22943386
Abstract

BACKGROUND

Long-term data on breast cancer detection in mammography screening programs are warranted to better understand the mechanisms by which screening changes the breast cancer pattern in the population. We aimed to analyze 17 years of breast cancer detection rates inside and outside screening in two Danish regions, emphasizing the influence of organizational differences of screening programs on the outcomes.

MATERIAL AND METHODS

We used data from two long-standing population-based mammography screening programs, Copenhagen and Fyn, in Denmark. Both programs offered biennial screening to women aged 50-69 years. We identified targeted, eligible, invited and participating women. We calculated screening detection and interval cancer rates for participants, and breast cancer incidence in non-screened women (= targeted women excluding participants) by biennial invitation rounds. Tumor characteristics were tabulated for each of the three groups of cancers.

RESULTS

Start of screening resulted in a prevalence peak in participants, followed by a decrease to a fairly stable detection rate in subsequent invitation rounds. A similar pattern was found for breast cancer incidence in non-screened women. In Fyn, non-screened women even had a higher rate than screening participants during the first three invitation rounds. The interval cancer rate was lower in Copenhagen than in Fyn, with an increase over time in Copenhagen, but not in Fyn. Screen-detected cancers showed tumor features related with a better prognosis than tumors detected otherwise, as more than 80% were smaller than 20 mm and estrogen receptor positive.

CONCLUSION

Data from two long-standing population-based screening programs in Denmark illustrated that even if background breast cancer incidence and organization were rather similar, performance indicators of screening could be strongly influenced by inclusion criteria and participation rates. Detection rates should be interpreted with caution as they may be biased by selection into the screening population.

摘要

背景

长期的乳腺癌筛查计划中的乳腺癌检出数据对于更好地了解筛查改变人群中乳腺癌模式的机制是必要的。我们旨在分析丹麦两个地区 17 年的乳腺癌筛查内外检出率,强调筛查计划的组织差异对结果的影响。

材料和方法

我们使用丹麦两个长期的基于人群的乳腺筛查计划(哥本哈根和菲英)的数据。这两个项目都为 50-69 岁的女性提供每两年一次的筛查。我们确定了目标、合格、受邀和参与的女性。我们计算了参与者的筛查检出率和间期癌率,以及非筛查女性(=排除参与者的目标女性)的每两年一次的邀请轮次的乳腺癌发病率。为每一组癌症列出了肿瘤特征。

结果

筛查的开始导致了参与者中的患病率高峰,随后在随后的邀请轮次中下降到相当稳定的检出率。在非筛查女性中也发现了类似的乳腺癌发病率模式。在菲英,非筛查女性在前三个邀请轮次中甚至比筛查参与者的发病率更高。哥本哈根的间期癌率低于菲英,且随着时间的推移而增加,但菲英没有增加。筛查检出的癌症与更好的预后相关的肿瘤特征比其他方式检出的肿瘤更明显,因为超过 80%的癌症小于 20 毫米,并且雌激素受体阳性。

结论

来自丹麦两个长期的基于人群的筛查计划的数据表明,即使背景乳腺癌发病率和组织相当相似,筛查的性能指标也可能受到纳入标准和参与率的强烈影响。检出率应谨慎解释,因为它们可能受到筛选人群选择的偏差影响。

相似文献

1
Seventeen-years overview of breast cancer inside and outside screening in Denmark.丹麦乳腺癌筛查内外 17 年概述。
Acta Oncol. 2013 Jan;52(1):48-56. doi: 10.3109/0284186X.2012.698750. Epub 2012 Sep 3.
2
Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.1991年4月至1997年3月哥本哈根乳腺癌的乳腺X线筛查。乳腺X线筛查评估小组。
APMIS Suppl. 1998;83:1-44.
3
Mammography screening in the county of Fyn. November 1993-December 1999.菲英岛县的乳腺钼靶筛查。1993年11月 - 1999年12月。
APMIS Suppl. 2003(110):1-33.
4
Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark.平衡敏感性和特异性:丹麦哥本哈根乳腺摄影筛查项目 16 年的经验。
Cancer Epidemiol. 2011 Oct;35(5):393-8. doi: 10.1016/j.canep.2010.12.001. Epub 2011 Jan 15.
5
Breast cancer incidence after the introduction of mammography screening: what should be expected?引入乳腺钼靶筛查后的乳腺癌发病率:预期会是怎样的情况?
Cancer. 2006 May 1;106(9):1883-90. doi: 10.1002/cncr.21823.
6
[Mammography screening in the county of Copenhagen. Results of the first three screening rounds].[哥本哈根县的乳腺X线筛查。前三轮筛查结果]
Ugeskr Laeger. 2002 Feb 18;164(8):1048-52.
7
Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.基于人群的亚洲女性乳腺癌筛查患病率及检测随机试验的中间测量结果:新加坡乳腺癌筛查项目
Cancer. 1998 Apr 15;82(8):1521-8.
8
Predicting the risk of a false-positive test for women following a mammography screening programme.预测乳腺钼靶筛查项目中女性假阳性检测的风险。
J Med Screen. 2007;14(2):94-7. doi: 10.1258/096914107781261891.
9
Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.针对有家族性或遗传易感性的女性,MRISC乳腺癌筛查项目首轮与后续轮次之间的差异。
Cancer. 2006 Jun 1;106(11):2318-26. doi: 10.1002/cncr.21863.
10
Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program.哥本哈根乳腺钼靶筛查项目中的过度诊断、停留时间和敏感度。
Breast J. 2006 Jul-Aug;12(4):338-42. doi: 10.1111/j.1075-122X.2006.00272.x.

引用本文的文献

1
Age-specific differences in tumour characteristics between screen-detected and non-screen-detected breast cancers in women aged 40-74 at diagnosis in Sweden from 2008 to 2017.2008 年至 2017 年期间,瑞典诊断时年龄在 40-74 岁的女性中,筛查检出和非筛查检出乳腺癌在肿瘤特征方面的年龄特异性差异。
J Med Screen. 2024 Dec;31(4):248-257. doi: 10.1177/09691413241237616. Epub 2024 Mar 7.
2
Quality assured implementation of the Slovenian breast cancer screening programme.保证实施斯洛文尼亚乳腺癌筛查计划的质量。
PLoS One. 2021 Oct 8;16(10):e0258343. doi: 10.1371/journal.pone.0258343. eCollection 2021.
3
Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark.
丹麦实施基于人群的筛查后乳腺癌死亡率及过度诊断情况
Breast Cancer Res Treat. 2020 Dec;184(3):891-899. doi: 10.1007/s10549-020-05896-9. Epub 2020 Aug 30.
4
DNA Methylation Heterogeneity Patterns in Breast Cancer Cell Lines.乳腺癌细胞系中的DNA甲基化异质性模式
Cancer Inform. 2016 Sep 7;15(Supple 4):1-9. doi: 10.4137/CIN.S40300. eCollection 2016.
5
Impact of invitation schemes on breast cancer screening coverage: A cohort study from Copenhagen, Denmark.邀请方案对乳腺癌筛查覆盖率的影响:丹麦哥本哈根的一项队列研究。
J Med Screen. 2017 Mar;24(1):20-26. doi: 10.1177/0969141316641982. Epub 2016 Jun 23.
6
Comparing sensitivity and specificity of screening mammography in the United States and Denmark.比较美国和丹麦乳腺钼靶筛查的敏感性和特异性。
Int J Cancer. 2015 Nov 1;137(9):2198-207. doi: 10.1002/ijc.29593. Epub 2015 Jun 1.
7
Body mass index and participation in organized mammographic screening: a prospective cohort study.体重指数与参加乳腺钼靶筛查:一项前瞻性队列研究。
BMC Cancer. 2015 Apr 17;15:294. doi: 10.1186/s12885-015-1296-8.
8
Breast cancer in European Union: an update of screening programmes as of March 2014 (review).欧盟的乳腺癌:截至 2014 年 3 月的筛查项目更新(综述)。
Int J Oncol. 2014 Nov;45(5):1785-92. doi: 10.3892/ijo.2014.2632. Epub 2014 Sep 1.